https://www.selleckchem.com/pr....oducts/ly2606368.htm
Minimally invasive aortic valve replacement (mini-AVR) might improve clinical outcomes, particularly in high-risk and elderly patients. Sutureless/rapid deployment bioprosthesis can offer advantage of decreasing the cross-clamp time (XCT) and easing the procedure. Our aim was to evaluate the safety and perioperative outcomes of mini-AVR using sutureless bioprothesis via the right minithoracotomy approach with our modified technique of central cannulation. We performed a single-center retrospective analysis of 203 patients consecutivel
Beğen
Yorum Yap
Paylaş
